Helixmith Co., Ltd (KOSDAQ:084990)
South Korea
· Delayed Price · Currency is KRW 2,855.00
+35.00 (1.24%)
Jun 19, 2025, 3:30 PM KST
Helixmith Revenue
Helixmith had revenue of 930.47M KRW in the quarter ending March 31, 2025, with 13.80% growth. This brings the company's revenue in the last twelve months to 5.09B, up 43.36% year-over-year. In the year 2024, Helixmith had annual revenue of 4.97B with 18.38% growth.
Revenue (ttm)
5.09B
Revenue Growth
+43.36%
P/S Ratio
25.84
Revenue / Employee
154.15M
Employees
33
Market Cap
131.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.97B | 772.35M | 18.38% |
| Dec 31, 2023 | 4.20B | 1.40B | 50.08% |
| Dec 31, 2022 | 2.80B | 483.36M | 20.87% |
| Dec 31, 2021 | 2.32B | -1.93B | -45.48% |
| Dec 31, 2020 | 4.25B | -206.22M | -4.63% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| HLB Co., Ltd. | 74.64B |
| PharmaResearch | 392.31B |
| Peptron | 4.30B |
Helixmith News
- 2 months ago - P/E Ratio Insights for Vipshop Holdings - Benzinga
- 9 months ago - Price Over Earnings Overview: Vipshop Holdings - Benzinga